A remarkably small bacterium containing fewer than 500 genes serves as the basis for one of the most detailed digital life ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years.

This is not pulp fiction. But a sign in the Great Gymnasium at Pompeii warns visitors not to enter 'if you think it may cause ...

Nissan presents the new 2026 X-Trail, the latest evolution of one of the world’s most recognised electrified family SUVs ...

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...

For decades, the phrase “incurable disease” has been considered a cold, impenetrable and definitive wall in medical sciences. In the room where the word “incurable” ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

The startup is developing AI foundation models trained on DNA rather than text or code, applying deep learning techniques to ...

Researchers have developed a high-tech system that rapidly scans ants and converts them into detailed 3D models. Using a synchrotron accelerator, X-ray imaging, robotics, and AI, the team scanned ...

Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

Researchers simulated nearly every molecule in a bacterial cell — and then watched the cell grow and reproduce.